Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review

Article English OPEN
Gostimir, Mišo; Bennett, Sean; Moyana, Terence; Sekhon, Harman; Martel, Guillaume;
(2016)
  • Publisher: BioMed Central
  • Journal: BMC Cancer,volume 16 (issn: 1471-2407, eissn: 1471-2407)
  • Related identifiers: pmc: PMC5057443, doi: 10.1186/s12885-016-2821-0
  • Subject: Complete pathological response | Borderline resectable | Pancreatic cancer | Genetics | FOLFIRINOX | Case report | Neoadjuvant therapy | Cancer Research | Oncology | Locally-advanced

Background Pancreatic cancer is among the top 5 most common cancers worldwide, but is particularly devastating due to its insidious nature. Complete surgical resection remains the only potential curative treatment, although only 20 % of patients present with a resectabl... View more
Share - Bookmark